Our Mission

To represent our members by providing leadership and support in the promotion of pharmaceutical care.  

AAHP serves its membership by pursuing common goals; through representation to private and public agencies and to the other health care organizations; and by promoting pharmacy as an essential component of the health care team.

AAHP 42nd Annual Fall Seminar

The Arkansas Association of Health-System Pharmacists 42nd Annual Fall Seminar will be October 9th and 10th at Grand Casino and Resort (property owned by Harrah’s) in Tunica, MS. The Fall Seminar CE programs will be held Thursday and Friday to provide over 10 hours of ACPE-accredited CE.

The AAHP Fall Seminar provides an excellent opportunity to make statewide health system pharmacy contacts in a relaxed atmosphere, and participants have been very pleased with the exposure they have received in years past.

More information will be posted here as it becomes available.

ASHP House of Delegates Press Release

The latest press release from the ASHP House of Delegates is available by clicking on the link below. The release will open in its own window.

Link

Pictures from the ASHP reception December 3, 2007 at the 42nd Midyear Clinical Meeting in Las Vegas

Impact of the Medicare Modernization Act - Challenges and Opportunities for Pharmacists

WEBINAR

A LIVE continuing education program for pharmacists via WEBINAR.
Pharmacy Law CE Topic.
Available on 2 dates at different times for your convenience.
Attend this FREE live program from your office or home –
Wherever is more convenient for you!

Thursday, April 3, 2008
12:00Noon - 1:00 pm EDT
and repeated on
Thursday, April 10, 2008
1:00 pm - 2:00 pm ED

Employment Opportunities Web Page

The AAHP website is sponsoring an a free employment opportunities page. Prospective employers can click on the link below and send the details, not to exceed the equivalent of 1 double-spaced typewritten page. Notices will be retired and removed in 30 days unless a 2 week extension is requested.

Link

FDA Advisory Committees Oppose OTC Status for Statins

Two FDA advisory committees on December 13 recommended that the agency not approve over-the-counter status for lovastatin 20 mg. During the joint meeting of the Nonprescription Drug Advisory Committee and the Endocrinologic Drugs Advisory Committee, ASHP voiced its opposition to the proposal, focusing its comments on the ongoing need to evaluate effectiveness and safety.

Link

ASHP Midyear Clinical Meeting Sets New Records in Las Vegas

It was a record-setting week for ASHP at the 42nd Midyear Clinical Meeting, December 2-6, in Las Vegas. More than 21,000 pharmacists, other health professionals, and pharmaceutical industry exhibitors were on hand for the educational, networking, and career advancement opportunities offered at the largest international meeting of pharmacists.

Link

Interrupt Deferasirox Therapy If Liver Enzymes Rise, Novartis Says

Novartis has strengthened its warning about the possibility of liver failure occurring during therapy with deferasirox, according to a letter circulated December 12 by FDA. The company wants clinicians to modify the iron-chelating agent's dosage or interrupt therapy for patients whose serum transaminase concentrations progressively increase or inexplicably remain elevated.

Link

First Drug Approved for Treatment of Phenylketonuria

FDA on December 13 announced that it approved the marketing of a drug that may help up to half of U.S. patients with phenylketonuria, an inborn metabolic disorder that can lead to mental retardation and other neurologic problems..

Merck Recalls PedvaxHIB, Comvax

Vaccine manufacturer Merck & Co. Inc. is recalling several lots of the pediatric vaccines PedvaxHIB and Comvax out of concern that they may not be sterile, according to a notice circulated December 12 by FDA and revised the next day.

Link

Gene Screen Asian Patients before Starting Carbamazepine

Patients of Asian ancestry are at increased risk for dangerous skin reactions to the anticonvulsant drug carbamazepine and should be tested for the presence of a specific immune-system gene variant before receiving the drug, FDA announced last week.

Link

ABC News Explains Why VA's Health Care System Is First-Rate

The Veterans Healthcare System's adoption of electronic medical records has enabled the giant provider to keep track of patients for a lifetime, reduce errors, and provide up-to-date evidence-based treatment.

Link

B & O Suppositories, Urised, Cystospaz Are Unapproved, FDA Says

In a recent warning letter to Amerifit Brands Inc., FDA said the firm's B & O rectal suppositories, Urised tablets, Cystospaz tablets, and Aquachloral rectal suppositories have not been approved for marketing in this country.

Link